Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TACE Associated With Systemic Chemotherapy Versus Systemic Chemotherapy in Patients Who Failed With First Line Chemotherapy

NCT03783559 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT03783559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03783559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TACE Associated With Systemic Chemotherapy Versus Systemic Chemotherapy in Patients Who Failed With First Line Chemotherapy
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2016
Completion date
March 31, 2021
Enrollment
168 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenocarcinoma metastatic to the liver